Genetically modified organisms, also known as GMOs, have been a hot topic of conversation among researchers, producers, ...

Cathie Wood's Ark Invest sold shares of five biotech and healthcare companies in recent trades. She also offloaded over 1.1 ...

Our new but simple method is far more effective and can now be applied to a much wider range of plant species than our ...

We have written about the promise of gene therapy to correct genetic disease many times. An exciting development happened ...

T cell therapies have revolutionized cancer treatment—but so far, their success has been largely limited to blood cancers. Solid tumors, which account for around 90% of all adult cancers, remain a ...

Key market opportunities for Cas12 proteins include rising government investments in biotech, increased demand for ...

Unveiling a new chapter in the understanding of human genetics, scientists have discovered a hidden geometric code within our ...

Cas9 gene editing and artificial intelligence to create compact tomato plants optimized for vertical farming in response to the dual challenges of climate change and urbanization.

Understanding how cells turn genes on and off is one of biology's most enduring mysteries. Now, a new technology developed by chemist Brian Liau and his collaborators at Harvard offers an ...

Innovation is never easy. It requires the audacity to create a new path, one where we will encounter novel obstacles that demand both resourcefulness and bold imagination. But when we stand together, ...

A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes towards the controversial approach.

CRISPR Therapeutics is anticipated to report higher revenues but a year-over-year decline in earnings for the quarter ended September 2025, with analyst expectations suggesting a possible earnings ...